Home » Topics » BioWorld Science

BioWorld Science
RSS

Vipergen enters derma drug discovery partnership with LEO Pharma

June 16, 2022

OliX subsidiary mCureX partners with Samyang and GC Pharma to advance mRNA vaccines

June 16, 2022

Genetic variants found in SLC35B2 gene tied to chondrodysplasia with hypomyelinating leukodystrophy

June 16, 2022

Variants in the PABP-domain of PABPC1 associated with developmental delay

June 16, 2022

Novel GLP-1 receptor agonist with improved oral bioavailability

June 16, 2022

U.S. researchers divulge new compounds for SARS-CoV-2 infection

June 16, 2022

Merck & Co. identifies new FXIa and/or KLKB1 inhibitors

June 16, 2022

Dunad Therapeutics and collaborators present new GTPase KRAS inhibitors

June 16, 2022

Denali Therapeutics divulges new LRP3 inflammasome inhibitors

June 16, 2022

Merck & Co. patents orexin OX2 receptor agonists

June 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...